These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9572129)

  • 1. Cancer controversy.
    Pollak M
    Nature; 1998 Apr; 392(6678):752. PubMed ID: 9572129
    [No Abstract]   [Full Text] [Related]  

  • 2. The potential role of somatostatin analogues in breast cancer treatment.
    Pollak M
    Yale J Biol Med; 1997; 70(5-6):535-9. PubMed ID: 9825480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hereditary neuroendocrine gastroenteropancreatic tumors and multiple endocrine neoplasia type 1].
    Scherübl H; Schaaf L; Raue F; Faiss S; Zeitz M
    Dtsch Med Wochenschr; 2004 Mar; 129(13):689-92. PubMed ID: 15026965
    [No Abstract]   [Full Text] [Related]  

  • 4. Antisecretory agents for prevention of post-ERCP pancreatitis: rationale for use and clinical results.
    Poon RT; Fan ST
    JOP; 2003 Jan; 4(1):33-40. PubMed ID: 12555014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of somatostatin and its analogues in prevention of postoperative complications after pancreaticoduodenectomy: a meta-analysis of randomized controlled trials.
    Zeng Q; Zhang Q; Han S; Yu Z; Zheng M; Zhou M; Bai J; Jin R
    Pancreas; 2008 Jan; 36(1):18-25. PubMed ID: 18192875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical treatment of endocrine gastroenteropancreatic tumors.
    Tomassetti P; Campana D; Nori F; Piscitelli L; Salomone L; Pezzilli R; Corinaldesi R
    JOP; 2006 Jan; 7(1):145-9. PubMed ID: 16407637
    [No Abstract]   [Full Text] [Related]  

  • 7. Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study.
    Andriulli A; Caruso N; Quitadamo M; Forlano R; Leandro G; Spirito F; De Maio G
    JOP; 2003 Jan; 4(1):41-8. PubMed ID: 12555015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: a North Central Cancer Treatment Group study.
    Burch PA; Block M; Schroeder G; Kugler JW; Sargent DJ; Braich TA; Mailliard JA; Michalak JC; Hatfield AK; Wright K; Kuross SA
    Clin Cancer Res; 2000 Sep; 6(9):3486-92. PubMed ID: 10999733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of somatostatin analogs in the treatment of neuroendocrine tumours and paraneoplastic syndromes].
    Sperlongano P; De Falco M; Pisaniello D; Parmeggiani D; Parmeggiani U
    Minerva Endocrinol; 2001 Dec; 26(4):293-5. PubMed ID: 11782719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Somatostatin in the treatment of pancreatic diseases].
    Németh AM
    Orv Hetil; 2002 May; 143(19 Suppl):1099-108. PubMed ID: 12063869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gastric cancer treatment controversy.
    van de Velde CJ; Peeters KC
    J Clin Oncol; 2003 Jun; 21(12):2234-6. PubMed ID: 12805321
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuroendocrine tumors--somatostatin receptor expression and somatostatin analog treatment.
    Janson ET; Oberg K
    Cancer Chemother Biol Response Modif; 2003; 21():535-46. PubMed ID: 15338762
    [No Abstract]   [Full Text] [Related]  

  • 13. Complete response after treatment with a somatostatin analogue in an adult patient with recurrent medulloblastoma.
    Glas M; Hennemann B; Hirschmann B; Marienhagen J; Schmidt-Wolf I; Herrlinger U; Bogdahn U; Hau P
    Acta Oncol; 2008; 47(3):479-80. PubMed ID: 17934891
    [No Abstract]   [Full Text] [Related]  

  • 14. Italy pulls plug on unproven cancer 'cure'.
    Abbott A
    Nature; 1998 Aug; 394(6693):514. PubMed ID: 9707104
    [No Abstract]   [Full Text] [Related]  

  • 15. [Role of somatostatin in the management of upper gastrointestinal bleeding].
    Herszényi L
    Orv Hetil; 2002 May; 143(19 Suppl):1092-9. PubMed ID: 12063868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms.
    Lissoni P
    Pathol Biol (Paris); 2007; 55(3-4):201-4. PubMed ID: 17446010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?
    Simone CB; Simone CB
    J Natl Cancer Inst; 2008 Nov; 100(21):1558-9; author reply 1559-1560. PubMed ID: 18957669
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjuvant trials design in colon cancer.
    Hendlisz A; Golfinopoulos V
    Curr Opin Oncol; 2009 Jul; 21(4):367-8. PubMed ID: 19444100
    [No Abstract]   [Full Text] [Related]  

  • 19. [Asymptomatic multinodular liver disease].
    Cadiot G
    Gastroenterol Clin Biol; 2003 May; 27(5 Suppl):B154-8. PubMed ID: 12843952
    [No Abstract]   [Full Text] [Related]  

  • 20. Somatostatin and its analogues in peptic ulcer bleeding: facts and pathophysiological aspects.
    Sgouros SN; Bergele C; Viazis N; Avgerinos A
    Dig Liver Dis; 2006 Feb; 38(2):143-8. PubMed ID: 16005698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.